NK 1 antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C546S207000, C546S208000, C546S209000, C546S210000, C546S212000, C546S214000, C544S124000

Reexamination Certificate

active

07041682

ABSTRACT:
Disclosed are NK1antagonists having the formula:Also disclosed are methods for treating a number of physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough, using the compounds of formula (I).

REFERENCES:
patent: 5620989 (1997-04-01), Harrison et al.
patent: 5760018 (1998-06-01), Baker et al.
patent: 2003/0158173 (2003-08-01), Paliwal et al.
patent: WO 94/10165 (1994-05-01), None
patent: WO 95/19344 (1995-07-01), None
Starykh et al. Relation of structure . . . CA 65:6503 (1966).
Ikizler et al. “Synthesis and biological activity . . . ” CA 129:260395 (1998).
Johnson et al. “A tachykinin receptor antagonist . . . ” CA 125:339038 (1996).
Harrison et al. “preparation of . . . ” CA 122:304898 (1995).
Patani et al. “Bioisosterim; a rational approach in drug design” Che, Rev. 96 3147-76 (1996).
Al-Sehemi et al “Kinetic resolution of amines . . . ” CA 137:5741 (2002).
Tavorath et al. “Drug treatment of chemotherapy induced delayed emesis” CA 126:205 (1996).
McAllister et al. “GR205171 blocks apomorphine . . . ” CA 129:254773 (1998).
Reid et al. “Comparison of the neurokinin-1 antagonist . . . ” CA 134:95359 (2000).
Campos et al. “Prevention of cisplatin-induced emesis . . . ” CA 135:190161 (2001).
Patent Cooperation Treaty International Search Report, PCT/US/03/20783 (CN01576K)—International Filing Date Feb. 7, 2003—3 Pages.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

NK 1 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with NK 1 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and NK 1 antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3544430

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.